| Teva Pharma AG - Trisenox 12 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 65178 | | 02 | | Trisenox 12 mg/6 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01XX27 | | Arsenic Trioxide | | 27.06.2019 | | |
|
| Composition |
| arsenii trioxidum 12 mg, natrii hydroxidum, natrii hydroxidi solutio 1 mol/L, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 6 ml corresp. natrium 4.14 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| | 12mg / 6ml |
| | BAG: Active Agent | Dose |
|---|
| | 12 mg |
| | | | Inactive agents | Dose |
|---|
| | | | | | | | 1 | | Sodium Hydroxide | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 10 | 3416.68 | 3732.25 | A | SL | No |
|
